Business ❯ Corporate Governance ❯ Investor Relations

Shareholder Actions

Class Action Participation Legal Compliance Class Action Lawsuits Class Action Cases Class Action Representation Legal Representation Securities Fraud Stock Acquisition Contingency Fees Litigation Risks

3 ARTICLES

4w ago

Shareholder Firms Seek Lead Plaintiff in Embecta Securities Suit Before August Deadline

A federal class action claims Embecta misled investors about revenue and pen‑needle sales and the court will appoint a lead plaintiff who will steer the case.

4 ARTICLES

last mo.

Multiple Law Firms Seek Lead Role in Commvault Securities Suit After $9.4M Executive Stock Sales

4 ARTICLES

2mo ago

Law Firms Press Medpace Investors to Seek Lead Role Before Early‑June Securities Class Action Deadline

4 ARTICLES

3mo ago

Medpace Hit With Securities Class Action Over Book-to-Bill and Cancellation Claims

8 ARTICLES

3mo ago

Pantera Leads Investor Push for Satsuma to Sell 646 BTC and Return Cash

4 ARTICLES

4mo ago

Law Firms Seek Masonite Investors for Securities Suit Over Alleged Buyback Misstatements

3 ARTICLES

4mo ago

Paysafe Investors Urged To Seek Lead Role In Securities Case Before Tuesday Deadline

8 ARTICLES

4mo ago

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

3 ARTICLES

4mo ago

Ramaco Investors Urged To Seek Lead Plaintiff Status Before March 31 Deadline

5 ARTICLES

4mo ago

Enphase Investor Suits Intensify as Firms Push April 20 Lead-Plaintiff Deadline

3 ARTICLES

4mo ago

Rosen and Schall Seek Lead Plaintiff in monday.com Securities Class Action

3 ARTICLES

5mo ago

Plaintiff Firms Seek PayPal Investors to Lead Securities Class Action Before April 20 Deadline

5 ARTICLES

5mo ago

Richtech Robotics Faces Securities Suits Over Alleged Microsoft Tie Claims as April 3 Lead-Plaintiff Deadline Nears

3 ARTICLES

6mo ago

Law Firms Seek Lead Plaintiffs in Ramaco Securities Case Over Brook Mine Disclosures

8 ARTICLES

6mo ago

Blue Owl Investors Face Feb. 2 Deadline to Seek Lead Role in Securities Suit

8 ARTICLES

6mo ago

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

7 ARTICLES

6mo ago

Skye Bioscience Investors Face Friday Deadline in Securities Class Action Over Nimacimab Disclosures

Shareholder Actions

Shareholder Firms Seek Lead Plaintiff in Embecta Securities Suit Before August Deadline

Multiple Law Firms Seek Lead Role in Commvault Securities Suit After $9.4M Executive Stock Sales

Securities Class Action Filed Against Zoetis Over Companion‑Animal Drug Claims

Securities Class Action Filed Over Commvault’s ARR Shortfall

Law Firms Compete to Lead Medpace Securities Suit Ahead of June 8 Deadline

Law Firms Press Medpace Investors to Seek Lead Role Before Early‑June Securities Class Action Deadline

Medpace Hit With Securities Class Action Over Book-to-Bill and Cancellation Claims

Pantera Leads Investor Push for Satsuma to Sell 646 BTC and Return Cash

Law Firms Seek Masonite Investors for Securities Suit Over Alleged Buyback Misstatements

Paysafe Investors Urged To Seek Lead Role In Securities Case Before Tuesday Deadline

Never miss stories about

Shareholder Actions

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Ramaco Investors Urged To Seek Lead Plaintiff Status Before March 31 Deadline

Enphase Investor Suits Intensify as Firms Push April 20 Lead-Plaintiff Deadline

Rosen and Schall Seek Lead Plaintiff in monday.com Securities Class Action

Plaintiff Firms Seek PayPal Investors to Lead Securities Class Action Before April 20 Deadline

Richtech Robotics Faces Securities Suits Over Alleged Microsoft Tie Claims as April 3 Lead-Plaintiff Deadline Nears

Law Firms Seek Lead Plaintiffs in Ramaco Securities Case Over Brook Mine Disclosures

Blue Owl Investors Face Feb. 2 Deadline to Seek Lead Role in Securities Suit

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

Skye Bioscience Investors Face Friday Deadline in Securities Class Action Over Nimacimab Disclosures

Never miss stories about

Shareholder Actions